IQVIA and LMC Manna Research to launch Prime Site in Canada
IQVIA has entered a strategic alliance with LMC Manna Research to launch its first Prime...
Read More...
Focus:
Canada
-
![Colcorona study]()
Montreal Heart Institute to continue COLCORONA study
Montreal Heart Institute in Canada has said that the COLCORONA clinical study, assessing colchicine, will...
Read More...
-
![Covid]()
Revive seeks approval to test Bucillamine for Covid-19
Revive Therapeutics has submitted a clinical trial application to Health Canada to conduct a Phase...
Read More...
-
![Canada vaccine]()
Health Canada approves first Covid-19 vaccine trials
The Canadian Center for Vaccinology (CCfV) at Dalhousie University has received approval from Health Canada...
Read More...
-
![coronavirus-1105]()
Appili Therapeutics submits clinical trial application with Health Canada
Anti-infective drug development-focused biopharmaceutical firm Appili Therapeutics has filed a clinical trial application (CTA) with...
Read More...
-
![CTA]()
Pivotal to conduct clinical trial on Covid-19 patients
European full-service contract research organisation (CRO) Pivotal is providing specialised clinical research services for conducting...
Read More...
-
![coronavirus-2_2303]()
Bausch Health initiates VIRAZOLE trial in Covid-19 patients
Bausch Health Companies has initiated a clinical trial programme in Canada to evaluate the investigational...
Read More...
-
![Cannalogue; Manitoba Covid-19 trials]()
Cannalogue and Manitoba prepare Covid-19 drug testing
Canada-based healthcare technology firm Cannalogue has applied to Health Canada seeking approval for a real-world...
Read More...
-
![Covid-19 trial; vaccine; plasma therapy]()
Covid-19 trials begin in the UK, Canada and Europe
Amid the rapid spread of the Covid-19 (coronavirus) infection, companies and researchers around the world...
Read More...
-
![]()
BELLUS Health completes patient enrolment in trial of BLU-5937
Canadian biopharmaceutical firm BELLUS Health has completed patient enrollment for its dose-escalation, placebo-controlled Phase II...
Read More...
